Cliff Asness's IRWD Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 6.47 M shares of Ironwood Pharmaceuticals, Inc. (IRWD) worth $27.22 M, representing 0.01% of the portfolio. First purchased in 2014-Q3, this long-term strategic position has been held for 42 quarters.
Based on 13F filings since 2013, Cliff Asness has maintained a long-term strategic position in IRWD, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2025, adding 3.64 M shares. Largest reduction occurred in Q2 2026, reducing 1.07 M shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Ironwood Pharmaceuticals (IRWD) Holding Value Over Time
Track share changes against reported price movement
Quarterly Ironwood Pharmaceuticals (IRWD) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -1.07 M | Reduce 14.19% | 6.47 M | $4.21 |
| Q1 2026 | +2.81 M | Add 59.52% | 7.54 M | $3.51 |
| Q4 2025 | -655,004 | Reduce 12.18% | 4.72 M | $3.37 |
| Q3 2025 | -787,102 | Reduce 12.77% | 5.38 M | $1.31 |
| Q2 2025 | +3.64 M | Add 144.29% | 6.17 M | $0.72 |
| Q1 2025 | +2.13 M | Add 535.76% | 2.52 M | $1.47 |
| Q4 2024 | -167,127 | Reduce 29.63% | 396,986 | $4.43 |
| Q3 2024 | -120,465 | Reduce 17.60% | 564,113 | $4.12 |
| Q2 2024 | +214,836 | Add 45.73% | 684,578 | $6.52 |
| Q1 2024 | +387,941 | Add 474.25% | 469,742 | $8.71 |
| Q4 2023 | -121,768 | Reduce 59.82% | 81,801 | $11.44 |
| Q3 2023 | -537,870 | Reduce 72.54% | 203,569 | $9.63 |
| Q2 2023 | +60,737 | Add 8.92% | 741,439 | $10.64 |
| Q1 2023 | +21,505 | Add 3.26% | 680,702 | $10.52 |
| Q4 2022 | +82,809 | Add 14.37% | 659,197 | $12.39 |
| Q3 2022 | +123,716 | Add 27.33% | 576,388 | $10.36 |
| Q2 2022 | +481 | Add 0.11% | 452,672 | $11.53 |
| Q1 2022 | +23,060 | Add 5.37% | 452,191 | $12.58 |
| Q4 2021 | +91,766 | Add 27.20% | 429,131 | $11.66 |
| Q3 2021 | -123,323 | Reduce 26.77% | 337,365 | $13.06 |
| Q2 2021 | -79,785 | Reduce 14.76% | 460,688 | $12.87 |
| Q1 2021 | +195,106 | Add 56.49% | 540,473 | $11.18 |
| Q4 2020 | +60,652 | Add 21.30% | 345,367 | $11.39 |
| Q3 2020 | -156,206 | Reduce 35.43% | 284,715 | $8.99 |
| Q2 2020 | +171,531 | Add 63.67% | 440,921 | $10.32 |
| Q1 2020 | +122,277 | Add 83.12% | 269,390 | $10.09 |
| Q4 2019 | +94,870 | Add 181.59% | 147,113 | $13.31 |
| Q3 2019 | -97,645 | Reduce 65.15% | 52,243 | $8.59 |
| Q2 2019 | +96,719 | Add 181.91% | 149,888 | $10.94 |
| Q1 2019 | +53,169 | New Buy | 53,169 | $13.52 |
| Q1 2018 | -13,389 | Sold Out | 0 | $0.00 |
| Q4 2017 | -14,109 | Reduce 51.31% | 13,389 | $15.01 |
| Q3 2017 | -27,549 | Reduce 50.05% | 27,498 | $15.78 |
| Q1 2017 | +8,629 | Add 18.59% | 55,047 | $17.06 |
| Q4 2016 | +6,075 | Add 15.06% | 46,418 | $15.30 |
| Q3 2016 | +40,343 | New Buy | 40,343 | $15.89 |
| Q3 2015 | -24,338 | Sold Out | 0 | $0.00 |
| Q2 2015 | -27,062 | Reduce 52.65% | 24,338 | $12.08 |
| Q1 2015 | +300 | Add 0.59% | 51,400 | $15.99 |
| Q4 2014 | -10,800 | Reduce 17.45% | 51,100 | $15.32 |
| Q3 2014 | +61,900 | New Buy | 61,900 | $12.96 |
Cliff Asness's Ironwood Pharmaceuticals Investment FAQs
Cliff Asness first purchased Ironwood Pharmaceuticals, Inc. (IRWD) in Q3 2014, acquiring 61,900 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Ironwood Pharmaceuticals, Inc. (IRWD) for 42 quarters since Q3 2014.
Cliff Asness's largest addition to Ironwood Pharmaceuticals, Inc. (IRWD) was in Q2 2025, adding 6,165,637 shares worth $4.42 M.
According to the latest 13F filing for Q2 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 6,465,921 shares of Ironwood Pharmaceuticals, Inc. (IRWD), valued at approximately $27.22 M.
As of the Q2 2026 filing, Ironwood Pharmaceuticals, Inc. (IRWD) represents approximately 0.01% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Ironwood Pharmaceuticals, Inc. (IRWD) was 7,535,080 shares, as reported at the end of Q1 2026.